Categories
- Anatomy
- Biochemistry
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Cardiology
- Cell Medicine
- Cell Therapy
- Chemistry
- DNA
- Embryology
- Future Medicine
- Gene Medicine
- Gene Therapy
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Human Genetics
- IVF Treatment
- Longevity Medicine
- Medical News
- Medical School
- Medical Technology
- Medicine
- Molecular Genetics
- Molecular Medicine
- Nano Medicine
- Nanotechnology
- Pet Stem Cell Therapy
- Stem Cell Therapy
Archives
Popular Search Keywords
Tag Archives: development
Response Genetics, Inc. Announces Presentations at the American Society of Clinical Oncology 2013 Annual Meeting
LOS ANGELES, May 20, 2013 (GLOBE NEWSWIRE) — Response Genetics, Inc. (RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, today announced that abstracts will be presented at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL May 31 to June 4, 2013. The abstracts demonstrate the clinical utility of Response Genetics’ proprietary ResponseDX(R) ERCC1 gene expression test in colon, pancreatic, and lung cancer and the emerging finding that gene mutation and expression profiles in colorectal cancer are associated with tumor location within the colon and rectum Continue reading
Posted in Genetics
Tagged annual-meeting, clinical, correlation, development, focused-on-the, generated, pharmaceutical, poster, poster-display, poster-session, press, research, response-genetics, securities, statements
Comments Off
Biotechnology ETF Investing 101
With ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S Continue reading
Posted in Biotechnology
Tagged 2013-as-generic, a-high-cash, biotech-sector, Biotechnology, central-nervous, development, industry, money, pharma, sector
Comments Off
Bioinformatics market to reach a total value of $7.5 billion by 2017
The bioinformatics market has been forecast to reach a total value of $7.5 billion by 2017, rising from a valuation of $3.2 billion at the end of 2012. The sector is driven by applications across a variety of sectors, including biotechnology, pharmaceutical research and development, agriculture, food safety, chemicals, manufacturing, and more recently, clinical genomics Continue reading
Posted in BioInformatics
Tagged a-total-value, better-equipped, better-informed, bioinformatics, development, generate-useful, such-as-image, united-states
Comments Off
98% of Your DNA is Junk – Video
98% of Your DNA is Junk New research shows our DNA is absolutely loaded with… NOTHING. 98 percent of our DNA plays no role in our development Continue reading
Posted in DNA
Tagged absolutely-loaded, development, DNA, findings, generated, our-development, research-shows, the-findings-, trace
Comments Off
Biotechnology in Drug Development Seminar_Training Philippines – Video
Biotechnology in Drug Development Seminar_Training Philippines Philippines Training/Seminar for 1500 PESOS with Lifetime Training/Seminar Certificate; Call/Text: +639081746221(Smart Buddy) SMARTMoneyAcct# 529967403256410… Continue reading
Posted in Biotechnology
Tagged buddy-, certificate, development, for-1500, generated, lifetime, lifetime-training, pesos, philippines, seminar-certificate, smart-buddy, training, training-philippines
Comments Off
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index
TARRYTOWN, N.Y., May 17, 2013 (GLOBE NEWSWIRE) — Progenics Pharmaceuticals, Inc. (PGNX) today announced that it has been selected for addition to the NASDAQ Biotechnology Index(R) (^NBI) effective prior to market open on Monday, May 20 Continue reading
Posted in Biotechnology
Tagged Biotechnology, development, generated, industry, information, ishares, japan, nasdaq, open-on-monday, performance, pharmaceutical, press, press-release
Comments Off
Anatomy of an Indie Hit: A Conversation with Ben Lewin – Video
Anatomy of an Indie Hit: A Conversation with Ben Lewin Co-production between BAFTA Los Angeles and the SAG Foundation. A discussion of Ben Lewin's extraordinary life and career and examination on the development,… Continue reading
Posted in Anatomy
Tagged angeles, career-and, conversation, development, foundation, generated, indie, lewin, life-and, sag, the-development, xamination-on-the
Comments Off
2013 School of Medicine Gala: Why Do I Give? – Video
2013 School of Medicine Gala: Why Do I Give? Brian J. DeFilippis, MS, Associate Dean for Development at the University of Maryland School of Medicine explains the importance of giving. Continue reading
Posted in Medicine
Tagged associate, associate-dean, development, evelopment-at-the, explains-the, explains-the-importance, generated, importance, maryland-, maryland-school, medi-, medicine-gala, school, university
Comments Off
Response Genetics, Inc. Announces Contract With Blue Shield of California
LOS ANGELES, May 16, 2013 (GLOBE NEWSWIRE) — Response Genetics, Inc. (RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, today announced that it has entered into an agreement with health insurer Blue Shield of California to join all of Blue Shield of California’s provider networks Continue reading
Posted in Genetics
Tagged blue, cross-blue, development, focused-on-the, medical, pharmaceutical, press, private, securities, statements
Comments Off
GENERAL EMBRYOLOGY FOR DENTAL SUDENTS COMPILED AND MODIFIED – Video
GENERAL EMBRYOLOGY FOR DENTAL SUDENTS COMPILED AND MODIFIED Diagrammatic representation of the development of the head and neck region for undergraduate students, particularly Oral Biology. The module is available thr… By: Yssa Lesmoras Continue reading
Posted in Embryology
Tagged and-, and-neck, available-thr-, Biology, development, for-, generated, head, lesmoras, region-for, the-development, the-head
Comments Off
Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index
NEW YORK, May 14, 2013 (GLOBE NEWSWIRE) — Synergy Pharmaceuticals Inc. (SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (R) (^NBI), effective prior to the market open on Monday, May 20. The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities classified according to the Industry Classification Benchmark (ICB) as either Biotechnology or Pharmaceuticals Continue reading
Posted in Biotechnology
Tagged annual-report, development, expectations, industry, nasdaq, performance, pharmaceuticals, requirements, securities, synergy-, treatment, year
Comments Off
Puma Biotechnology to Present at UBS Global Healthcare Conference
LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. (PBYI), a development stage biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will present an overview of the Company at 2:30 p.m Continue reading
Posted in Biotechnology
Tagged anticipated, archived-on-the, chairman, commercial-use, conference-will, development, further-develop, information, press-release, treatment, website-at-www
Comments Off
Synthetic Biology Could Speed Flu Vaccine Production
Advanced genetic engineering is already changing vaccine development and could make inroads into other branches of medicine. Synthetic biology is breathing new life into the old-fashioned world of vaccine production, raising hopes that manufacturers could release vaccines much more quickly when outbreaks occur. At a meeting on synthetic biology held at MIT, the drug company Novartis said it has synthesized hybrid flu genomes in a process that could shave weeks off the time required to produce vaccines Continue reading
Posted in Biology
Tagged a-new-outbreak-, a-viral-genome, boston, branches, cambridge, cells, china, development, generated, produce-malaria, swiss, team, technology-, time
Comments Off
NeoStem's Subsidiary, Progenitor Cell Therapy, to Provide Autologous and Allogeneic Cellular Therapy Services to …
ALLENDALE, N.J. Continue reading
Posted in Cell Therapy
Tagged center, chairman, customer, development, generated, georgetown, hospital, management, medical, president, progenitor, service-, theurer, united-states
Comments Off
BG Medicine Reports 2013 First Quarter Financial Results
Abbott and bioMerieux Obtain CE Mark and Launch Galectin-3 Tests in EU BGM Galectin-3 Revenues Coupled With Operational Discipline Drive Improved Financial Results WALTHAM, Mass., May 9, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. Continue reading
Posted in Medicine
Tagged adopted-the-bgm, architect, chief-executive, compared-with, development, financial, galectin-3, Medicine, merieux-obtain, organization, president, recent-business, same, trenton-health, united-states
Comments Off
Research and Markets: Analysis of the U.S. Interventional Radiology and Cardiology X-ray Equipment Market – New Growth …
DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/xdzpkf/analysis_of_the_u) has announced the addition of Frost & Sullivan’s new report “Analysis of the U.S. Continue reading
Posted in Cardiology
Tagged a-role-either, competitive, current, development, generated, market, markets, outlook-on-the, research, x-ray-equipment
Comments Off
Plandai Biotechnology, Inc. Announces Distribution Agreement With Natural Products For Weight Management Product Using …
SEATTLE, May 9, 2013 /PRNewswire/ –Plandai Biotechnology, Inc. (PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced a distribution agreement which grants Natural Products the exclusive rights in South Africa to develop and market a weight management product using Plandai’s Phytofare Catechin Extract. Natural Products specializes in producing and selling Maxi nutraceuticals through an Internet client base and directly to pharmacists and wellness retailers in South Africa Continue reading
Posted in Biotechnology
Tagged a-dynamic-and, Biotechnology, callum-baylis-, development, extract, extract-natural, highly-bioavailable, internet, marketing-sales, phytofare, phytofare-catechin, plandai, weight-loss
Comments Off
Research and Markets: Personalized Medicine – Scientific and Commercial Aspects – Updated 2013 Report
DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/c247cv/personalized) has announced the addition of Jain PharmaBiotech’s new report “Personalized Medicine – Scientific and Commercial Aspects” to their offering. The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. Continue reading
Posted in Medicine
Tagged a-system-are, development, family, generated, match-the-right, pharmaceutical, report, study, the-development
Comments Off
Puma Biotechnology to Present at Bank of America Merrill Lynch 2013 Health Care Conference
LOS ANGELES–(BUSINESS WIRE)– Puma Biotechnology, Inc. Continue reading
Posted in Biotechnology
Tagged america-merrill, anticipated, chairman, chief-executive, development, encore, focused-on-the, generated, health, information, press, press-release, securities, website-at-www
Comments Off